Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | DPP4 | P27487 | 7/20 | 0.45 |
| ▸ | FAP | Q12884 | 4/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250459 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL28833359 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL163395 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL122347 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL201078 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL173401 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL159315 | 0.98 | ALDH1A1 (0.50) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| Hydrochloric Acid SCHEMBL6826101 | 0.95 | ALDH1A1 (0.48) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL22029349 | 0.95 | ALDH1A1 (0.48) | ALDH1A1DPP7MEN1KMT2AKDM4E | |
| SCHEMBL17338009 | 0.95 | ALDH1A1 (0.48) | ALDH1A1DPP7MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2017-05-11 | — | — | US | disclosed |
| WO-2015192037-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | BUSATH DAVID D (US) | 2015-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | HVCN1, TRPM8, TRPM2 | ALDH1A1 3851/4885DPP7 856/4885MEN1 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.